The role of brachytherapy (interventional radiotherapy) for primary and/or recurrent vulvar cancer: a Gemelli Vul.Can multidisciplinary team systematic review

V. Lancellotta, Gabriella Macchia, Giorgia Garganese, B. Fionda, Simona Maria Fragomeni, Andrea D'Aviero, C. Casà, Benedetta Gui, Stefano Gentileschi, Giacomo Corrado, Frediano Inzani, A. Rovirosa, A. G. Morganti, Alessio Giuseppe Morganti, Maria Antonietta Gambacorta, Luca Tagliaferri

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Objective: The aim of our systematic review was to assess the role of interventional radiotherapy (IRT, brachytherapy) in the management of primary and/or recurrent vulvar carcinoma. Evidence acquisition: A systematic research using PubMed, Scopus and Cochrane library was performed. ClinicalTrials.gov was searched for ongoing or recently completed trials, and PROSPERO was searched for ongoing or recently completed systematic reviews. Only full-text English-language articles related to IRT for treatment of primary or recurrent VC were identified and reviewed. Conference paper, survey, letter, editorial, book chapter and review were excluded. Time restriction (1990–2018) as concerns the years of the publication was considered. Evidence synthesis: Primary disease: the median 5-year LC was 43.5% (range 19–68%); the median 5-year DFS was 44.5% (range 44–81%); the median 5-year OS was 50.5% (range 27–85%). Recurrent disease: the median 5-year DFS was 64% (range 56–72%) and the median 5-year OS was 45% (range 33%-57%). Acute ≥ grade 2 toxicity was reported in three patients (1.6%). The severe late toxicity rates (grade 3–4) ranged from 0% to 14.3% (median 7.7%). Conclusion: IRT as part of primary treatment for primary and/or recurrent vulvar cancer is associated with promising clinical outcomes.
Lingua originaleEnglish
pagine (da-a)1611-1619
Numero di pagine9
RivistaCLINICAL & TRANSLATIONAL ONCOLOGY
Volume2021
DOI
Stato di pubblicazionePubblicato - 2021

Keywords

  • Advanced vulvar cancer
  • Brachytherapy
  • Interventional radiotherapy
  • Outcomes
  • Recurrences
  • Toxicity

Fingerprint

Entra nei temi di ricerca di 'The role of brachytherapy (interventional radiotherapy) for primary and/or recurrent vulvar cancer: a Gemelli Vul.Can multidisciplinary team systematic review'. Insieme formano una fingerprint unica.

Cita questo